Garcia Marino
SEC CIK 1669866 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | CEO AND Pres, Dir | 231.3K | — | $27.96M | 5 | 2026-03-12 | 2026-08-07 |
Most active insiders at DNTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Garcia Marino | CEO AND Pres, Dir | — | $27.96M |
| 2 | Randhawa Simrat | EVP, Head of R, D | — | $15.00M |
| 3 | Savitz Ryan | EVP, CFO, CBO | — | $14.29M |
| 4 | CARR EDWARD | CAO | — | $5.59M |
| 5 | Veness Adam M | SVP, GC, Sec | — | $4.63M |
| 6 | Soteropoulos Paula | Dir | — | $2.25M |
| 7 | McGeorge Anne | Dir | — | $844.8K |
| 8 | Read Simon | Dir | — | $630.8K |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-07 18:30 | 2026-08-07 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Garcia Marino | CEO AND Pres, Dir | M - OptEx | $8.44 | +166.0K | 231.3K | +254% | +$1.40M |
| DMT | 2026-08-07 18:30 | 2026-08-07 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Garcia Marino | CEO AND Pres, Dir | S - Sale+OE | $108.11 | -166.0K | 65.3K | -72% | -$17.95M |
| DM | 2026-03-17 | 2026-03-16 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Garcia Marino | CEO AND Pres, Dir | M - OptEx | $7.66 | +65.3K | 65.3K | New | +$500.0K |
| DMT | 2026-03-13 | 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Garcia Marino | CEO AND Pres, Dir | S - Sale+OE | $81.49 | -122.9K | 0 | -100% | -$10.02M |
| DT | 2026-03-13 | 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Garcia Marino | CEO AND Pres, Dir | M - OptEx | $6.70 | +122.9K | 122.9K | New | +$823.6K |
Purchase Sale Sale after option exercise All abbreviations